title: Cyclic peptides as potential therapeutic agents for skin disorders.
abstract: There is an increasing understanding of the role of peptides in normal skin function and skin disease. With this knowledge, there is significant interest in the application of peptides as therapeutics in skin disease or as cosmeceuticals to enhance skin appearance. In particular, antimicrobial peptides and those involved in inflammatory processes provide options for the development of new therapeutic directions in chronic skin conditions such as psoriasis and dermatitis. To exploit their potential, it is essential that these peptides are delivered to their site of action in active form and in sufficient quantity to provide the desired effect. Many polymers permeate the skin poorly and are vulnerable to enzymatic degradation. Synthesis of cyclic peptide derivatives can substantially alter the physicochemical characteristics of the peptide with the potential to improve its skin permeation. In addition, cyclization can stabilize the peptide structure and thereby increase its stability. This review describes the role of cyclic peptides in the skin, examples of current cyclic peptide therapeutic products, and the potential for cyclic peptides as dermatological therapeutics and cosmeceuticals.
authors.affiliation: Curtin Health Innovation Research Institute, School of Pharmacy, Curtin University, Perth, WA, Australia.
authors.forename: Sarika
authors.initials: S
authors.lastname: Namjoshi
authors.forename: Heather A E
authors.initials: HA
authors.lastname: Benson
mesh_terms: D000595:Amino Acid Sequence; D000890:Anti-Infective Agents / Q000737:chemistry / Q000627:therapeutic use; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D008969:Molecular Sequence Data; D015394:Molecular Structure; D010456:Peptides, Cyclic / Q000737:chemistry / Q000235:genetics / Q000627:therapeutic use*; D055550:Protein Stability; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D010456:Peptides, Cyclic